These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


952 related items for PubMed ID: 26469188

  • 1. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.
    Kauffman KJ, Dorkin JR, Yang JH, Heartlein MW, DeRosa F, Mir FF, Fenton OS, Anderson DG.
    Nano Lett; 2015 Nov 11; 15(11):7300-6. PubMed ID: 26469188
    [Abstract] [Full Text] [Related]

  • 2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K, Sundaresan A, Cheow WS.
    Eur J Pharm Biopharm; 2013 Nov 11; 85(3 Pt A):427-43. PubMed ID: 23872180
    [Abstract] [Full Text] [Related]

  • 3. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL, Hajj KA, Vizelman J, Bajaj P, Whitehead KA.
    Nano Lett; 2018 Jun 13; 18(6):3814-3822. PubMed ID: 29694050
    [Abstract] [Full Text] [Related]

  • 4. Preparation and Optimization of Lipid-Like Nanoparticles for mRNA Delivery.
    Li B, Dong Y.
    Methods Mol Biol; 2017 Jun 13; 1632():207-217. PubMed ID: 28730441
    [Abstract] [Full Text] [Related]

  • 5. The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants.
    Blakney AK, McKay PF, Ibarzo Yus B, Hunter JE, Dex EA, Shattock RJ.
    ACS Nano; 2019 May 28; 13(5):5920-5930. PubMed ID: 31046232
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
    Zhang R, El-Mayta R, Murdoch TJ, Warzecha CC, Billingsley MM, Shepherd SJ, Gong N, Wang L, Wilson JM, Lee D, Mitchell MJ.
    Biomater Sci; 2021 Feb 21; 9(4):1449-1463. PubMed ID: 33404020
    [Abstract] [Full Text] [Related]

  • 14. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK, Davaa E, Myung CS, Park JS.
    Int J Pharm; 2010 Jun 15; 392(1-2):141-7. PubMed ID: 20347025
    [Abstract] [Full Text] [Related]

  • 15. Peptide/Lipid-Associated Nucleic Acids (PLANAs) as a Multicomponent siRNA Delivery System.
    Hall R, Alasmari A, Mozaffari S, Mahdipoor P, Parang K, Montazeri Aliabadi H.
    Mol Pharm; 2021 Mar 01; 18(3):986-1002. PubMed ID: 33496597
    [Abstract] [Full Text] [Related]

  • 16. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
    Ho EA, Osooly M, Strutt D, Masin D, Yang Y, Yan H, Bally M.
    J Pharm Sci; 2013 Jan 01; 102(1):227-36. PubMed ID: 23132529
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery.
    Qin Y, Walters AA, Rouatbi N, Wang JT, Abdel-Bar HM, Al-Jamal KT.
    Biomaterials; 2023 Aug 01; 299():122158. PubMed ID: 37243988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M, Li Y, Bloomer H, Xu Q.
    Acc Chem Res; 2021 Nov 02; 54(21):4001-4011. PubMed ID: 34668716
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.